Allstate Corp Has $3.32 Million Stock Holdings in CME Group Inc. $CME

Key Points

• Allstate Corp increased its stake in CME Group Inc by 17.3%, owning a total of 12,530 shares valued at approximately $3.32 million.
• Multiple institutional investors have recently bought shares in CME Group, contributing to the fact that 87.75% of the company's stock is owned by institutional investors.
• CME Group announced a quarterly dividend of $1.25 per share, reflecting an annualized dividend of $5.00 and a yield of 1.9%.

Allstate Corp boosted its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 17.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,530 shares of the financial services provider's stock after buying an additional 1,844 shares during the period. Allstate Corp's holdings in CME Group were worth $3,324,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. GQG Partners LLC increased its position in shares of CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after purchasing an additional 2,176,685 shares during the period. Wellington Management Group LLP increased its position in shares of CME Group by 370.5% during the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after purchasing an additional 2,089,935 shares during the period. GAMMA Investing LLC increased its position in shares of CME Group by 32,941.0% during the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after purchasing an additional 1,853,261 shares during the period. Nuveen LLC bought a new stake in shares of CME Group during the first quarter valued at approximately $218,842,000. Finally, Egerton Capital UK LLP increased its position in shares of CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock valued at $459,003,000 after purchasing an additional 765,773 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 500 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 0.5%

Shares of CME Group stock traded down $1.49 during trading hours on Wednesday, hitting $270.12. The company's stock had a trading volume of 1,396,860 shares, compared to its average volume of 2,322,688. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $97.35 billion, a PE ratio of 26.15, a price-to-earnings-growth ratio of 4.91 and a beta of 0.44. CME Group Inc. has a 12 month low of $207.75 and a 12 month high of $290.79. The stock has a 50 day moving average of $275.93 and a 200 day moving average of $268.87.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the company earned $2.56 earnings per share. Analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Citigroup boosted their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. UBS Group reaffirmed a "neutral" rating and set a $305.00 price target on shares of CME Group in a research note on Thursday, July 24th. Barclays set a $298.00 price target on CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Finally, Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $261.93.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.